Newsroom | 70931 results

LYON, France--(BUSINESS WIRE)--MaaT Pharma Provides an Update on the Application for Marketing Authorization of MaaT013 (Xervyteg®) in the treatment of aGvHD...

SCHLIEREN, Switzerland & SAN DIEGO--(BUSINESS WIRE)--InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of high-content imaging and phenotypic assay technologies based in San Diego, California. The acquisition marks an important new chapter for PhenoVista Biosciences, enabling the company to significantly expand its scientific and commercial impact by c...

MADISON, Wis.--(BUSINESS WIRE)--FUJIFILM Cellular Dynamics, Inc., a pioneering global developer and manufacturer of human-induced pluripotent stem cells (iPSCs), today celebrated the opening of its new headquarters and iPSC development and manufacturing facility in its Madison home. The new site is expected to quadruple the capacity for the company’s iPSC-based research products and services manufacturing footprint and expand capabilities across FUJIFILM Cellular Dynamics’ research product port...

SAN CARLOS, Calif.--(BUSINESS WIRE)--Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company (“Lilly”). Engage is developing the Tethosome platform, a novel non-viral DNA delivery system designed to overcome key limitations in DNA delivery, including potency, tolerability, and redosability. The platform combines engineered DNA payloads with lipid nanoparticle delivery and an mRNA-...

SAARBRÜCKEN, Germany--(BUSINESS WIRE)--New peer-reviewed research published by ki:elements and the PROSPECT-AD consortium demonstrates that the company’s Speech Biomarker for Cognition (SB-C) can reliably detect cognitive impairment and signal underlying Alzheimer’s disease (AD) pathology through an AI voice agent that calls participants at home. The study, involving 736 participants across five independent cohorts in Spain, the UK, Germany and Sweden, is one of the largest and most geographica...

PITTSBURGH--(BUSINESS WIRE)--CytoAgents expanded its Scientific Advisory Board with the appointments of Dr. Michael Wechsler and Dr. Johann Gudjonsson to support pipeline growth....

MADISON, Wis.--(BUSINESS WIRE)--Invenra, Inc., a biotechnology company pioneering multispecific antibody therapeutics, today announced the appointment of Nancy J. Sandy as Chief Commercial Officer. The hire marks a significant step in the Invenra strategy to bring its expanding platform portfolio, including its B-Body® bispecific and newly launched T-Body™ trispecific antibody platforms, to pharmaceutical and biotech partners worldwide. Invenra enters this next chapter with strong momentum. The...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Predicta Biosciences, a company building ultra-sensitive molecular and immune diagnostic platforms, today announced the appointment of Craig L. Tendler, M.D., as an independent director to its Board of Directors. Dr. Tendler brings decades of experience designing and executing oncology and hematology development programs including the integration of biomarkers and diagnostics, from early development and proof of concept through registration. Over the course of...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials, today announced a strategic collaboration with Pfizer Inc. to advance the development of Pfizer’s oncology portfolio through a science‑driven and scaled research program designed to bring promising therapies to patients faster and closer to home. Central to the collaboration is SCRI’s Accelero™, a next-generation clinic...

NEW YORK--(BUSINESS WIRE)--As oncology grows more complex and the pace of innovation accelerates, life sciences organizations are placing a premium on high-quality, complete, and scalable real-world data. New insights from two independent surveys confirm that data quality and cohort scale are now prerequisites for confident decision-making and insight generation, especially as the industry evolves from retrospective analysis to predictive and AI-driven applications. A survey conducted by Deloit...